ÂÜÀòÂÒÂ×

Mark Lehmkuhle is the founder, CEO, and CTO of Epitel, a company that specializes in developing artificial intelligence software for medical applications. Prior to Epitel, Lehmkuhle was a research assistant professor at the University of Utah in the Department of Neurosurgery. There, they worked on developing AI software to help with diagnosing and treating brain tumors.

Mark Lehmkuhle began their educational career with a BS in Biomedical Engineering from Case Western Reserve University. Mark then went on to get their PhD in Bioengineering from the University of Utah. Finally, they completed their education with a postdoctoral degree in Biomedical Engineering from the University of Michigan College of Engineering.

Rob Lingstuyl - Software Architect, Kevin Gao - Software Engineer, and Matt Parrott - VP, Manufacturing report to Mark Lehmkuhle.